Filing Details
- Accession Number:
- 0001181431-10-059703
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-06 20:15:01
- Reporting Period:
- 2010-12-02
- Filing Date:
- 2010-12-06
- Accepted Time:
- 2010-12-06 20:15:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
927066 | Davita Inc | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1415548 | Javier Rodriguez | C/O Davita Inc. 1551 Wewatta St. Denver CO 80202 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-12-02 | 150,000 | $49.70 | 223,814 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-12-02 | 100,689 | $74.04 | 123,125 | No | 4 | F | Direct | |
Common Stock | Disposition | 2010-12-02 | 49,311 | $74.05 | 73,814 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Right | Disposition | 2010-12-02 | 150,000 | $0.00 | 150,000 | $49.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-07-01 | 2011-07-01 | No | 4 | M | Direct |
Footnotes
- The range of prices for the sale of these shares was $74.00 - $74.23. The filer undertakes to provide staff, the issuer, or a security holder full information regarding the number of hsares sold at each separate price.
- Stock Appreciation Right, pursuant to the 2002 Equity Compensation Plan, which vest 25% on the first annviersary of the grant date, 8.33% on the 20th month following the grant date, and 8.33% every 4 months thereafter until fully vested.